Rehab Mohamed Elgharabawy

Ambroxol, a mucolytic agent, boosts <scp>HO</scp> ‐1, suppresses <scp>NF‐κB</scp> , and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitis

Simona Cavalu, Hossam Sharaf, Sameh Saber et al. · The FASEB Journal · 2022 · 47 citations

Life Sciences, Pharmacology, Pharmacotherapy +17

Carbocisteine as a Modulator of Nrf2/HO-1 and NFκB Interplay in Rats: New Inspiration for the Revival of an Old Drug for Treating Ulcerative Colitis

Mahmoud E. Youssef, Simona Cavalu, Gomaa Mostafa‐Hedeab et al. · Frontiers in Pharmacology · 2022 · 38 citations · Full text

Life Sciences, Immunology, Pharmacology +17

A novel therapeutic combination of dapagliflozin, Lactobacillus and crocin attenuates diabetic cardiomyopathy in rats: Role of oxidative stress, gut microbiota, and PPARγ activation

Eman M. Khalaf, Hanan M. Hassan, Ahmed M. El-Baz et al. · European Journal of Pharmacology · 2022 · 28 citations

Medicine, Cardiology, Pharmacology +17

RETRACTED: Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling

Sameh Saber, Eslam E. Abd El-Fattah, Ahmed A.E. Mourad et al. · Biomedicine & Pharmacotherapy · 2023 · 28 citations · Full text

Medicine, Oncology, Pharmacology +16

Nifuroxazide-loaded cubosomes exhibit an advancement in pulmonary delivery and attenuate bleomycin-induced lung fibrosis by regulating the STAT3 and NF-κB signaling: A new challenge for unmet therapeutic needs

Sameh Saber, Mohamed Nasr, Mohamed M.Y. Kaddah et al. · Biomedicine & Pharmacotherapy · 2022 · 24 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17